{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:19:38Z","timestamp":1767863978570,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia","doi-asserted-by":"publisher","award":["NN-1-038\/10"],"award-info":[{"award-number":["NN-1-038\/10"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.pharep.2015.06.003","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T04:51:34Z","timestamp":1434689494000},"page":"75-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride"],"prefix":"10.1007","volume":"68","author":[{"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Gilowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2015.06.003_bib0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2015.06.003_bib0195","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/CIRCULATIONAHA.106.658948","article-title":"Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study","volume":"115","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharep.2015.06.003_bib0200","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","article-title":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.2 million people","volume":"117","author":"Schramm","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharep.2015.06.003_bib0205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2013.02.010","article-title":"Diabetes and altered glucose metabolism with aging","volume":"42","author":"Kalyani","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.pharep.2015.06.003_bib0210","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2337\/diab.43.2.212","article-title":"Insulin resistance, body fat distribution, and sex hormones in men","volume":"43","author":"Haffner","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.pharep.2015.06.003_bib0215","first-page":"682","article-title":"Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: the Telecom Study","volume":"82","author":"Simon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2015.06.003_bib0220","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/oxfordjournals.aje.a115732","article-title":"Endogenous sex hormone levels in older men with diabetes mellitus","volume":"132","author":"Barrett-Connor","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharep.2015.06.003_bib0225","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1210\/jc.2004-0804","article-title":"Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes","volume":"89","author":"Dhindsa","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2015.06.003_bib0230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.2005.02299.x","article-title":"Androgens, insulin resistance and vascular disease in men","volume":"63","author":"Kapoor","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharep.2015.06.003_bib0235","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/diacare.23.4.490","article-title":"Testosterone, sex hormone binding globulin and the development of type 2 diabetes in middle aged men","volume":"23","author":"Stellato","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharep.2015.06.003_bib0240","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/oxfordjournals.aje.a008832","article-title":"Low levels of sex hormone binding globulin and testosterone predict the development of non-insulin dependent diabetes mellitus in men","volume":"143","author":"Haffner","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharep.2015.06.003_bib0245","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/HJR.0b013e32833c1a8d","article-title":"Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia","volume":"18","author":"Haring","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.pharep.2015.06.003_bib0250","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2796.2006.01637.x","article-title":"Low testosterone levels are associated with carotid atherosclerosis in men","volume":"259","author":"Svartberg","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharep.2015.06.003_bib0255","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archinte.167.12.1252","article-title":"Sex steroids and all-cause and cause-specific mortality in men","volume":"167","author":"Araujo","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharep.2015.06.003_bib0260","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Endogenous testosterone and mortality in men: a systematic review and meta-analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2015.06.003_bib0265","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MED.0b013e3283383031","article-title":"Androgens and cardiovascular disease","volume":"17","author":"Yeap","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.pharep.2015.06.003_bib0270","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000319635","article-title":"Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies \u2013 a mini-review","volume":"57","author":"M\u00e4kinen","year":"2011","journal-title":"Gerontology"},{"key":"10.1016\/j.pharep.2015.06.003_bib0275","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study","volume":"87","author":"Feldman","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2015.06.003_bib0280","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/13685530500130969","article-title":"Investigation, treatment and monitoring of late-onset hypogonadism in males","volume":"8","author":"Nieschlag","year":"2005","journal-title":"Aging Male"},{"key":"10.1016\/j.pharep.2015.06.003_bib0285","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ecl.2013.02.012","article-title":"Reproductive aging in men","volume":"42","author":"Basaria","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.pharep.2015.06.003_bib0290","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.beem.2013.05.002","article-title":"Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes","volume":"27","author":"Corona","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12 Pt 2","key":"10.1016\/j.pharep.2015.06.003_bib0295","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1301\/nr.2007.dec.S253-S259","article-title":"Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity","volume":"65","author":"Ridker","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pharep.2015.06.003_bib0300","doi-asserted-by":"crossref","first-page":"2P","DOI":"10.1016\/j.amjcard.2006.09.014","article-title":"Inflammatory biomarkers in stable atherosclerosis","volume":"98","author":"Kinlay","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharep.2015.06.003_bib0305","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2015.06.003_bib0310","doi-asserted-by":"crossref","first-page":"1563S","DOI":"10.1093\/ajcn\/86.5.1563S","article-title":"Homocysteine, vitamins, and vascular disease prevention","volume":"86","author":"McCully","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharep.2015.06.003_bib0315","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2165\/00003495-200363170-00005","article-title":"Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes","volume":"63","author":"Krysiak","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.pharep.2015.06.003_bib0320","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1368-5031.2005.00571.x","article-title":"Type 2 diabetes mellitus: a cardiovascular perspective","volume":"59","author":"Varughese","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.pharep.2015.06.003_bib0325","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MED.0000000000000044","article-title":"Type 2 diabetes and cardiovascular disease: what next","volume":"21","author":"Joseph","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2015.06.003_bib0330","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s11739-013-0914-1","article-title":"Testosterone and cardiovascular risk","volume":"8","author":"Tirabassi","year":"2013","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.pharep.2015.06.003_bib0335","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2164\/jandrol.108.007245","article-title":"The dark side of testosterone deficiency: III. Cardiovascular disease","volume":"30","author":"Traish","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.pharep.2015.06.003_bib0340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.metabol.2012.06.009","article-title":"The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose","volume":"62","author":"Krysiak","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.pharep.2015.06.003_bib0345","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.atherosclerosis.2012.09.034","article-title":"Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose","volume":"225","author":"Krysiak","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2015.06.003_bib0350","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/138161209787315729","article-title":"Pleiotropic effects of statins-clinical evidence","volume":"15","author":"Athyros","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharep.2015.06.003_bib0355","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2008.08.022","article-title":"The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis","volume":"203","author":"Blum","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2015.06.003_bib0360","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.coph.2013.01.004","article-title":"Anti-atherosclerotic mechanisms of statin therapy","volume":"13","author":"Babelova","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharep.2015.06.003_bib0365","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1507\/endocrj.EJ13-0332","article-title":"Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes","volume":"60","author":"Sato","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.pharep.2015.06.003_bib0370","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2796.2003.01213.x","article-title":"Effects of short-term treatment with metformin on serum concentrations of homocysteine folate and vitamin B12 in type 2 diabetes mellitus: a randomized placebo-controlled trial","volume":"254","author":"Wulffel\u00e9","year":"2003","journal-title":"J Intern Med"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015001176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015001176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:09Z","timestamp":1752611769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.06.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1734114015001176"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.06.003","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}